In a country with more than 170 million people, we have patient availability, fast patient enrollment, lower costs and quality study investigators.
- Patient Availability - A highly urbanized population and fewer competing clinical studies helps speed patient enrollment.
- Lower Cost - Compared to U.S. and Europe, clinical trial development is less expensive in Brazil.
- Geographic Localization - Brazil is in the opposite hemisphere compared to U.S. and Europe. Therefore, Brazil is a key place for clinical study for seasonal diseases studies.